Literature DB >> 17098107

Calcium-phosphorus product and troponin-T values in renal failure.

Keith Wrenn1, Robert Blair, Fritz F Parl, RuAnn Schleicher.   

Abstract

PURPOSE: The purpose of this study was to see if there is a significant association between calcium-phosphorus product (CPP) and initial troponin-T values in patients with renal insufficiency. BASIC PROCEDURES: A retrospective study over 4 months from the laboratory database of all patients with serum creatinine values greater than 3 mg/dL who had concomitant troponin T and creatine kinase isoenzymes measured was conducted. The most recent calcium and phosphorus values were also abstracted.
RESULTS: There were 87 patients with a mean age of 59 years, a median creatinine value of 51 mg/dL, a mean CPP of 47, and a median initial troponin-T value of 0.18 ng/mL. The troponin level was elevated (>0.05 ng/mL) in 74% of the patients. The CPP was higher than 55 in 28% of the patients. When comparing the troponin values with the CPP, there was no association noted (P = .72).
CONCLUSIONS: Although both elevated CPP and troponin values are associated with increased cardiovascular mortality in the intermediate term, we could not demonstrate a useful relationship between the 2 values that would indicate causality or help with the interpretation of the initial troponin level when patients with renal insufficiency present with suspected acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098107     DOI: 10.1016/j.ajem.2006.03.012

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Is cardiac biomarkers and left ventricular function affected by chronic kidney disease?

Authors:  Amir Farhang Zand Parsa; Alireza Abdolahi; Mitra Mahdavimazdeh
Journal:  Indian Heart J       Date:  2012-08-27

2.  Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG.

Authors:  Xiang Li; Lingtong Shan; Mengwei Lv; Zhi Li; Chunyan Han; Ban Liu; Wen Ge; Yangyang Zhang
Journal:  BMC Cardiovasc Disord       Date:  2020-10-28       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.